Ceritinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Ceritinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. Your doctor will test for the presence of this gene. Ceritinib is an antineoplastic (cancer) agent.Ceritinib Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Ceritinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)-N-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of Ceritinib Nitroso Impurity 2 . We supply Ceritinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142211 |
| CAS No | NA |
| Mol.F. | C18H20N4O2 |
| Mol.Wt. | 324.38 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142212 |
| CAS No | NA |
| Mol.F. | C18H18N4O3 |
| Mol.Wt. | 338.37 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142213 |
| CAS No | NA |
| Mol.F. | C19H22N4O3 |
| Mol.Wt. | 354.41 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142214 |
| CAS No | NA |
| Mol.F. | C19H18N4O3 |
| Mol.Wt. | 350.38 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142215 |
| CAS No | NA |
| Mol.F. | C17H20N4O2 |
| Mol.Wt. | 312.37 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0142216 |
| CAS No | NA |
| Mol.F. | C7H15N3O3S |
| Mol.Wt. | 221.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142217 |
| CAS No | NA |
| Mol.F. | C16H23N3O3 |
| Mol.Wt. | 305.38 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142218 |
| CAS No | NA |
| Mol.F. | C18H27N7O3 |
| Mol.Wt. | 389.46 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142219 |
| CAS No | NA |
| Mol.F. | C9H17N3O3 |
| Mol.Wt. | 215.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142220 |
| CAS No | NA |
| Mol.F. | C19H26N6O5 |
| Mol.Wt. | 418.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142221 |
| CAS No | NA |
| Mol.F. | C24H29N9O5 |
| Mol.Wt. | 523.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142222 |
| CAS No | NA |
| Mol.F. | C18H24N6O5 |
| Mol.Wt. | 404.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142223 |
| CAS No | NA |
| Mol.F. | C28H38N10O5 |
| Mol.Wt. | 594.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142224 |
| CAS No | NA |
| Mol.F. | C11H13N5O3 |
| Mol.Wt. | 263.26 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142225 |
| CAS No | NA |
| Mol.F. | C18H20N6O5 |
| Mol.Wt. | 400.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142226 |
| CAS No | NA |
| Mol.F. | C13H18N6O3 |
| Mol.Wt. | 306.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |